Log in to save to my catalogue

Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and...

Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3042627073

Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study

About this item

Full title

Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study

Publisher

Oxford: Hindawi

Journal title

Journal of clinical pharmacy and therapeutics, 2024, Vol.2024 (1)

Language

English

Formats

Publication information

Publisher

Oxford: Hindawi

More information

Scope and Contents

Contents

Metformin/glipizide tablets are a compound formulation composed of metformin hydrochloride and glipizide. This study aimed to assess the pharmacokinetics and bioequivalence of two fixed-dose combination (FDC) tablets of metformin/glipizide (500 mg/2.5 mg) in healthy Chinese subjects. We conducted a single-center, open-label, randomized, two-way cro...

Alternative Titles

Full title

Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3042627073

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3042627073

Other Identifiers

ISSN

0269-4727

E-ISSN

1365-2710

DOI

10.1155/2024/9200636

How to access this item